Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Indeterminate genotypes of hepatitis C virus by the Abbott RealTime HCV Genotype II assay in Morocco. About eight cases resolved by a sequencing method.

Mesbahi Z, Kabbaj H, Malki H, Bouihat N, Qrafli M, Belefquih B, Marcil S, Challine D, Pawlotsky JM, Bouvier M, Seffar M.

J Med Virol. 2018 Aug;90(8):1352-1357. doi: 10.1002/jmv.25191. Epub 2018 Apr 26.

PMID:
29663433
2.

Performance of rapid diagnostic tests for the detection of anti-HBs in various patient populations.

Poiteau L, Soulier A, Roudot-Thoraval F, Hézode C, Challine D, Pawlotsky JM, Chevaliez S.

J Clin Virol. 2017 Nov;96:64-66. doi: 10.1016/j.jcv.2017.09.012. Epub 2017 Sep 28.

PMID:
28982043
3.

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

Fourati S, Challine D, Poveda JD, Laperche S, Rallier S, Pawlotsky JM, Chevaliez S.

J Clin Virol. 2017 Jul;92:69-74. doi: 10.1016/j.jcv.2017.05.015. Epub 2017 May 17.

PMID:
28549336
4.

Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice.

Wolfromm A, Rodriguez C, Michel M, Habibi A, Audard V, Benayoun E, Rogier O, Challine D, Chosidow O, Lelièvre JD, Chevalier X, Le Bras F, Pautas C, Imbert M, Pawlotsky JM, Wagner-Ballon O.

Br J Haematol. 2015 Jul;170(2):192-9. doi: 10.1111/bjh.13421. Epub 2015 Apr 28.

PMID:
25920561
5.

Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations.

Chevaliez S, Challine D, Naija H, Luu TC, Laperche S, Nadala L, Allain JP, Lee HH, Pawlotsky JM.

J Clin Virol. 2014 Feb;59(2):89-93. doi: 10.1016/j.jcv.2013.11.010. Epub 2013 Dec 1.

6.

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.

Delfau-Larue MH, de Leval L, Joly B, Plonquet A, Challine D, Parrens M, Delmer A, Salles G, Morschhauser F, Delarue R, Brice P, Bouabdallah R, Casasnovas O, Tilly H, Gaulard P, Haioun C.

Haematologica. 2012 Oct;97(10):1594-602. doi: 10.3324/haematol.2011.061507. Epub 2012 Feb 27.

7.

Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.

Lascaux AS, Caumes E, Deback C, Melica G, Challine D, Agut H, Lévy Y.

J Med Virol. 2012 Feb;84(2):194-7. doi: 10.1002/jmv.23188.

PMID:
22170537
8.

[Guidelines concerning stat laboratory process].

Challine D, Dhondt JL, Szymanowicz A; membres du sous-groupe 1 pré-analytique.

Ann Biol Clin (Paris). 2010 Dec;68 Spec No 1:147-54. French.

PMID:
21613012
9.

[Guidelines for medical prescription of medical laboratory tests].

Challine D, Flourié F, Pfeffer J, Serre-Debeauvais F, Szymanowicz A; membres du sous-groupe 1 pré-analytique.

Ann Biol Clin (Paris). 2010 Dec;68 Spec No 1:23-41. French.

PMID:
21613006
10.

Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.

Challine D, Chevaliez S, Pawlotsky JM.

Gastroenterology. 2008 Oct;135(4):1185-91. doi: 10.1053/j.gastro.2008.07.011. Epub 2008 Jul 17.

PMID:
18694749
11.

Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit.

Girou E, Chevaliez S, Challine D, Thiessart M, Morice Y, Lesprit P, Tkoub-Scheirlinck L, Soing-Altrach S, Cizeau F, Cavin C, André M, Dahmanne D, Lang P, Pawlotsky JM.

Clin Infect Dis. 2008 Sep 1;47(5):627-33. doi: 10.1086/590564.

PMID:
18662134
12.

A new cause of 'gloves and socks' syndrome: chicken pox.

Duong TA, Poszepczynska-Guigné E, Challine D, Poulalhon N, Revuz J, Bagot M, Wolkenstein P.

J Eur Acad Dermatol Venereol. 2009 Mar;23(3):329-30. doi: 10.1111/j.1468-3083.2008.02869.x. Epub 2008 Jun 11. No abstract available.

PMID:
18554215
13.

Serological viral testing of cadaveric cornea donors.

Challine D, Roudot-Thoraval F, Sabatier P, Dubernet F, Larderie P, Rigot P, Pawlotsky JM.

Transplantation. 2006 Sep 27;82(6):788-93.

PMID:
17006326
14.

HIV and hepatitis C virus RNA in seronegative organ and tissue donors.

Challine D, Pellegrin B, Bouvier-Alias M, Rigot P, Laperche L, Pawlotsky JM.

Lancet. 2004 Oct 30-Nov 5;364(9445):1611-2.

PMID:
15519632
15.

Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C.

Oniankitan O, Duvoux C, Challine D, Mallat A, Chevalier X, Pawlotsky JM, Claudepierre P.

J Rheumatol. 2004 Jan;31(1):107-9.

PMID:
14705228
16.

Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.

Challine D, Buisson M, Cadilhac M, Germanidis G, Joab I, Eliaszewicz M, Caumes E, Flahault A, Fillet AM, Pawlotsky JM, Seigneurin JM.

J Med Virol. 2002 Aug;67(4):510-5.

PMID:
12115996
17.

Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.

Eliaszewicz M, Flahault A, Roujeau JC, Fillet AM, Challine D, Mansouri S, Wolkenstein P, Aractingi S, Penso-Assathiany D, Maslo C, Bourgault-Villada I, Chosidow O, Caumes E; Epitox Study Group.

J Am Acad Dermatol. 2002 Jul;47(1):40-6.

PMID:
12077579
18.

Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses.

Challine D, Roudot-Thoraval F, Sarah T, Laperche L, Boisson B, Mauberquez S, Dubernet F, Rigot P, Lefrère F, Mercier B, Brossard Y, Rouet F, Girot R, Loiseau P, Girard D, Claquin J, Loty B, Lerable J, Mariotti M, Pawlotsky JM, Lefrère JJ.

Transfusion. 2001 Sep;41(9):1120-5.

PMID:
11552068
19.

Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man.

Lechapt-Zalcman E, Challine D, Delfau-Larue MH, Haioun C, Desvaux D, Gaulard P.

Arch Pathol Lab Med. 2001 Sep;125(9):1246-8.

PMID:
11520284
20.

Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution.

Allory Y, Challine D, Haioun C, Copie-Bergman C, Delfau-Larue MH, Boucher E, Charlotte F, Fabre M, Michel M, Gaulard P.

Am J Surg Pathol. 2001 Jul;25(7):865-74.

PMID:
11420457
21.

Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies.

Belloc C, Baird S, Cosme J, Lecoeur S, Gautier JC, Challine D, de Waziers I, Flinois JP, Beaune PH.

Toxicology. 1996 Jan 8;106(1-3):207-19.

PMID:
8571393
22.

Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation.

Vassal G, Koscielny S, Challine D, Valteau-Couanet D, Boland I, Deroussent A, Lemerle J, Gouyette A, Hartmann O.

Cancer Chemother Pharmacol. 1996;37(3):247-53.

PMID:
8529285
23.

Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.

Lecoeur S, Bonierbale E, Challine D, Gautier JC, Valadon P, Dansette PM, Catinot R, Ballet F, Mansuy D, Beaune PH.

Chem Res Toxicol. 1994 May-Jun;7(3):434-42.

PMID:
8075377
24.

Busulfan disposition below the age of three: alteration in children with lysosomal storage disease.

Vassal G, Fischer A, Challine D, Boland I, Ledheist F, Lemerle S, Vilmer E, Rahimy C, Souillet G, Gluckman E, et al.

Blood. 1993 Aug 1;82(3):1030-4.

PMID:
8338934
25.

Chronopharmacology of high-dose busulfan in children.

Vassal G, Challine D, Koscielny S, Hartmann O, Deroussent A, Boland I, Valteau-Couanet D, Lemerle J, Lévi F, Gouyette A.

Cancer Res. 1993 Apr 1;53(7):1534-7.

26.

Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?

Vassal G, Deroussent A, Challine D, Hartmann O, Koscielny S, Valteau-Couanet D, Lemerle J, Gouyette A.

Blood. 1992 May 1;79(9):2475-9.

PMID:
1571560
27.

Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study.

Vassal G, Deroussent A, Hartmann O, Challine D, Benhamou E, Valteau-Couanet D, Brugières L, Kalifa C, Gouyette A, Lemerle J.

Cancer Res. 1990 Oct 1;50(19):6203-7.

Supplemental Content

Loading ...
Support Center